1910
We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery.
Y Combinator
yc-company-directory #4012We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery.
source1910 is classified as AI agents from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.
Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.
Companies similar to 1910
A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.
Origami Therapeutics, Inc.
match 92Origami Therapeutics, Inc. is a biotech company developing novel protein degraders with potential to delay or halt disease progression by eliminating toxic proteins from the body. Our drug discovery platform leverages our proprietary human disease models developed to select the small molecules with the best chance of clinical success. Our first indication is Huntington’s disease, a debilitating, progressive and ultimately fatal disorder caused by a genetic mutation. We have already identified sm
shared extracted concept terms: model, drug, discovery; shared product terms: biotech, small, molecule, therapeutic; shared product theme: health and clinical care; shared affiliation: Y Combinator
Valence Discovery
match 57Valence is unlocking the true potential of deep learning in drug design by unifying best-in-class deep learning technologies with intuitive infrastructure to allow any drug discovery team to become AI-enabled. We're proudly headquartered at Mila.
shared extracted concept terms: enabl, drug; shared product terms: discovery, infrastructure, enabl, drug; shared product theme: developer infrastructure
AfterQuery
match 55AfterQuery is an applied research lab curating data solutions for frontier foundation model development. Serving every frontier AI lab.
shared extracted concept terms: frontier, model, lab; shared product terms: frontier, model, lab; shared affiliation: Y Combinator
Biolinco
match 54Biolinco develops an AI-enabled, high-throughput cell line screening platform for biopharmaceutical manufacturers to efficiently identify optimal cell lines using DNA barcoding technology, addressing the issue of low-yielding cell lines
shared extracted concept terms: high, throughput, enabl; shared product terms: high, throughput, enabl
Synapsica Healthcare
match 50AI-enabled automation of diagnostic radiology workflow and reporting.
shared extracted concept terms: automation, enabl; shared product terms: automation, enabl; shared product theme: workflow automation, health and clinical care; same category: AI agents; shared affiliation: Y Combinator
Velvet
match 17The multimodal data lab.
shared product terms: multimodal, lab; shared affiliation: Y Combinator